ReP USP - Resultado da busca

Artigo de periodico-carta/editorial
Purinergic signalling in the central nervous system and its pharmacological importance in neurological and psychiatric illnesses [Editorial] (2024)
Tang, Yong ; Rubini, Patrizia; Sperlagh, Beata; Ulrich, Henning
Fonte: Frontiers Pharmacology. Unidade: IQ
Assuntos: SISTEMA NERVOSO CENTRAL, DOENÇAS DO SISTEMA NERVOSO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TANG, Yong et al. Purinergic signalling in the central nervous system and its pharmacological importance in neurological and psychiatric illnesses [Editorial]. Frontiers Pharmacology. Lausanne: Instituto de Química, Universidade de São Paulo. Disponível em: https://dx.doi.org/10.3389/fphar.2023.1355286. Acesso em: 12 nov. 2024. , 2024
APA
Tang, Y., Rubini, P., Sperlagh, B., & Ulrich, H. (2024). Purinergic signalling in the central nervous system and its pharmacological importance in neurological and psychiatric illnesses [Editorial]. Frontiers Pharmacology. Lausanne: Instituto de Química, Universidade de São Paulo. doi:10.3389/fphar.2023.1355286
NLM
Tang Y, Rubini P, Sperlagh B, Ulrich H. Purinergic signalling in the central nervous system and its pharmacological importance in neurological and psychiatric illnesses [Editorial] [Internet]. Frontiers Pharmacology. 2024 ; 14 1-2 art. 1355286.[citado 2024 nov. 12 ] Available from: https://dx.doi.org/10.3389/fphar.2023.1355286
Vancouver
Tang Y, Rubini P, Sperlagh B, Ulrich H. Purinergic signalling in the central nervous system and its pharmacological importance in neurological and psychiatric illnesses [Editorial] [Internet]. Frontiers Pharmacology. 2024 ; 14 1-2 art. 1355286.[citado 2024 nov. 12 ] Available from: https://dx.doi.org/10.3389/fphar.2023.1355286
Artigo de periodico
Regulation of GABAergic neurotransmission by purinergic receptors in brain physiology and disease (2024)
Juvenal, Guilherme Araújo ; Higa, Guilherme Shigueto Vilar ; Marques, Lucas Bonfim; Zampieri, Thais Tessari; Viana, Felipe José Costa ; Britto, Luiz Roberto Giorgetti de ; Tang, Yong; Illes, Peter ; Virgilio, Francesco Di ; Ulrich, Henning ; Pasquale, Roberto de
Fonte: Purinergic Signalling. Unidades: ICB, IQ
Assuntos: NEUROTRANSMISSORES, RECEPTORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JUVENAL, Guilherme Araújo et al. Regulation of GABAergic neurotransmission by purinergic receptors in brain physiology and disease. Purinergic Signalling, 2024Tradução . . Disponível em: https://dx.doi.org/10.1007/s11302-024-10034-x. Acesso em: 12 nov. 2024.
APA
Juvenal, G. A., Higa, G. S. V., Marques, L. B., Zampieri, T. T., Viana, F. J. C., Britto, L. R. G. de, et al. (2024). Regulation of GABAergic neurotransmission by purinergic receptors in brain physiology and disease. Purinergic Signalling. doi:10.1007/s11302-024-10034-x
NLM
Juvenal GA, Higa GSV, Marques LB, Zampieri TT, Viana FJC, Britto LRG de, Tang Y, Illes P, Virgilio FD, Ulrich H, Pasquale R de. Regulation of GABAergic neurotransmission by purinergic receptors in brain physiology and disease [Internet]. Purinergic Signalling. 2024 ;[citado 2024 nov. 12 ] Available from: https://dx.doi.org/10.1007/s11302-024-10034-x
Vancouver
Juvenal GA, Higa GSV, Marques LB, Zampieri TT, Viana FJC, Britto LRG de, Tang Y, Illes P, Virgilio FD, Ulrich H, Pasquale R de. Regulation of GABAergic neurotransmission by purinergic receptors in brain physiology and disease [Internet]. Purinergic Signalling. 2024 ;[citado 2024 nov. 12 ] Available from: https://dx.doi.org/10.1007/s11302-024-10034-x
Artigo de periodico
Purinergic receptors in cognitive disturbances (2023)
Illes, Peter ; Ulrich, Henning ; Chen, Jiang Fan ; Tang, Yong
Fonte: Neurobiology of Disease. Unidade: IQ
Assuntos: TRANSTORNOS MENTAIS, DOENÇAS NEURODEGENERATIVAS, RECEPTORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ILLES, Peter et al. Purinergic receptors in cognitive disturbances. Neurobiology of Disease, v. 185, p. 1-16, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.nbd.2023.106229. Acesso em: 12 nov. 2024.
APA
Illes, P., Ulrich, H., Chen, J. F., & Tang, Y. (2023). Purinergic receptors in cognitive disturbances. Neurobiology of Disease, 185, 1-16. doi:10.1016/j.nbd.2023.106229
NLM
Illes P, Ulrich H, Chen JF, Tang Y. Purinergic receptors in cognitive disturbances [Internet]. Neurobiology of Disease. 2023 ; 185 1-16.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/j.nbd.2023.106229
Vancouver
Illes P, Ulrich H, Chen JF, Tang Y. Purinergic receptors in cognitive disturbances [Internet]. Neurobiology of Disease. 2023 ; 185 1-16.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/j.nbd.2023.106229
Parte de monografia/livro
Purinergic signaling in neurogenesisand neural fate determination: current knowledge and future challenges (2023)
Caetano, Roberta Andrejew ; Turrini, Natalia ; Ye, Qing ; Tang, Yong ; Illes, Peter ; Ulrich, Henning
Fonte: Purinergic signaling in neurodevelopment, neuroinflammation and neurodegeneration. Unidade: IQ
Assuntos: NEURÔNIOS, SISTEMA NERVOSO CENTRAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAETANO, Roberta Andrejew et al. Purinergic signaling in neurogenesisand neural fate determination: current knowledge and future challenges. Purinergic signaling in neurodevelopment, neuroinflammation and neurodegeneration. Tradução . Cham: Springer, 2023. . . Acesso em: 12 nov. 2024.
APA
Caetano, R. A., Turrini, N., Ye, Q., Tang, Y., Illes, P., & Ulrich, H. (2023). Purinergic signaling in neurogenesisand neural fate determination: current knowledge and future challenges. In Purinergic signaling in neurodevelopment, neuroinflammation and neurodegeneration. Cham: Springer.
NLM
Caetano RA, Turrini N, Ye Q, Tang Y, Illes P, Ulrich H. Purinergic signaling in neurogenesisand neural fate determination: current knowledge and future challenges. In: Purinergic signaling in neurodevelopment, neuroinflammation and neurodegeneration. Cham: Springer; 2023. [citado 2024 nov. 12 ]
Vancouver
Caetano RA, Turrini N, Ye Q, Tang Y, Illes P, Ulrich H. Purinergic signaling in neurogenesisand neural fate determination: current knowledge and future challenges. In: Purinergic signaling in neurodevelopment, neuroinflammation and neurodegeneration. Cham: Springer; 2023. [citado 2024 nov. 12 ]
Artigo de periodico
Purinergic signalling in cancer therapeutic resistance: From mechanisms to targeting strategies (2023)
Jia, Wenhui; Huang, Zhao; Zhou, Li; Liou, Yih-Cherng; Virgilio, Francesco Di ; Ulrich, Henning ; Peter, Illes; Zhang, Wei; Huang, Canhua ; Tang, Yong
Fonte: Drug Resistance Updates. Unidade: IQ
Assuntos: NEOPLASIAS, PURINAS, PROLIFERAÇÃO CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JIA, Wenhui et al. Purinergic signalling in cancer therapeutic resistance: From mechanisms to targeting strategies. Drug Resistance Updates, v. 70, p. 1-13 art. 100988, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.drup.2023.100988. Acesso em: 12 nov. 2024.
APA
Jia, W., Huang, Z., Zhou, L., Liou, Y. -C., Virgilio, F. D., Ulrich, H., et al. (2023). Purinergic signalling in cancer therapeutic resistance: From mechanisms to targeting strategies. Drug Resistance Updates, 70, 1-13 art. 100988. doi:10.1016/j.drup.2023.100988
NLM
Jia W, Huang Z, Zhou L, Liou Y-C, Virgilio FD, Ulrich H, Peter I, Zhang W, Huang C, Tang Y. Purinergic signalling in cancer therapeutic resistance: From mechanisms to targeting strategies [Internet]. Drug Resistance Updates. 2023 ; 70 1-13 art. 100988.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/j.drup.2023.100988
Vancouver
Jia W, Huang Z, Zhou L, Liou Y-C, Virgilio FD, Ulrich H, Peter I, Zhang W, Huang C, Tang Y. Purinergic signalling in cancer therapeutic resistance: From mechanisms to targeting strategies [Internet]. Drug Resistance Updates. 2023 ; 70 1-13 art. 100988.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/j.drup.2023.100988
Artigo de periodico
Decoupling SERT-nNOS interaction to generate fast-onset antidepressants (2023)
Ye, Qing; Lin, Si‑Si; Ulrich, Henning ; Tang, Yong
Fonte: Neuroscience Bulletin. Unidade: IQ
Assuntos: HIDRÓLISE, ESPECTROSCOPIA INFRAVERMELHA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YE, Qing et al. Decoupling SERT-nNOS interaction to generate fast-onset antidepressants. Neuroscience Bulletin, v. 39, n. 8, p. 1327-1329, 2023Tradução . . Disponível em: https://doi.org/10.1007/s12264-023-01049-2. Acesso em: 12 nov. 2024.
APA
Ye, Q., Lin, S. ‑S., Ulrich, H., & Tang, Y. (2023). Decoupling SERT-nNOS interaction to generate fast-onset antidepressants. Neuroscience Bulletin, 39( 8), 1327-1329. doi:10.1007/s12264-023-01049-2
NLM
Ye Q, Lin S‑S, Ulrich H, Tang Y. Decoupling SERT-nNOS interaction to generate fast-onset antidepressants [Internet]. Neuroscience Bulletin. 2023 ; 39( 8): 1327-1329.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1007/s12264-023-01049-2
Vancouver
Ye Q, Lin S‑S, Ulrich H, Tang Y. Decoupling SERT-nNOS interaction to generate fast-onset antidepressants [Internet]. Neuroscience Bulletin. 2023 ; 39( 8): 1327-1329.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1007/s12264-023-01049-2
Artigo de periodico
Purinergic signaling in cognitive impairment and neuropsychiatric symptoms of Alzheimer’s disease (2023)
Ribeiro, Deidiane Elisa ; Petiz, Lyvia Lintzmaier ; Glaser, Talita ; Giacomelli, Ágatha Oliveira ; Andrejew, Roberta ; Saab, Fernando de Azevedo Ribeiro; Milanis, Milena da Silva ; Campos, Henrique Correia; Sampaio, Vanessa Fernandes Arnaud ; La Banca, Sophia; Longo, Beatriz Monteiro ; Lameu, Claudiana ; Tang, Yong; Resende, Rodrigo Ribeiro ; Ferreira, Sergio T ; Ulrich, Henning
Fonte: Neuropharmacology. Unidade: IQ
Assuntos: NEUROPSIQUIATRIA, DOENÇA DE ALZHEIMER, DEPRESSÃO, TRANSTORNOS DO SONO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIBEIRO, Deidiane Elisa et al. Purinergic signaling in cognitive impairment and neuropsychiatric symptoms of Alzheimer’s disease. Neuropharmacology, v. 226, p. 1-16 art. 109371, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2022.109371. Acesso em: 12 nov. 2024.
APA
Ribeiro, D. E., Petiz, L. L., Glaser, T., Giacomelli, Á. O., Andrejew, R., Saab, F. de A. R., et al. (2023). Purinergic signaling in cognitive impairment and neuropsychiatric symptoms of Alzheimer’s disease. Neuropharmacology, 226, 1-16 art. 109371. doi:10.1016/j.neuropharm.2022.109371
NLM
Ribeiro DE, Petiz LL, Glaser T, Giacomelli ÁO, Andrejew R, Saab F de AR, Milanis M da S, Campos HC, Sampaio VFA, La Banca S, Longo BM, Lameu C, Tang Y, Resende RR, Ferreira ST, Ulrich H. Purinergic signaling in cognitive impairment and neuropsychiatric symptoms of Alzheimer’s disease [Internet]. Neuropharmacology. 2023 ; 226 1-16 art. 109371.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/j.neuropharm.2022.109371
Vancouver
Ribeiro DE, Petiz LL, Glaser T, Giacomelli ÁO, Andrejew R, Saab F de AR, Milanis M da S, Campos HC, Sampaio VFA, La Banca S, Longo BM, Lameu C, Tang Y, Resende RR, Ferreira ST, Ulrich H. Purinergic signaling in cognitive impairment and neuropsychiatric symptoms of Alzheimer’s disease [Internet]. Neuropharmacology. 2023 ; 226 1-16 art. 109371.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/j.neuropharm.2022.109371
Artigo de periodico
Various facets of excitotoxicity (2022)
Glaser, Talita ; Silva, Jean Bezerra ; Juvenal, Guilherme Araújo ; Maiolini, Pedro Negrão; Turrini, Natalia ; Petiz, Lyvia Lintzmaier ; Marques, Lucas Bonfim; Ribeiro, Deidiane Elisa ; Ye, Qing; Tang, Yong ; Ulrich, Henning
Fonte: Exploration of Neuroprotective Therapy. Unidade: IQ
Assuntos: MITOCÔNDRIAS, AMINOÁCIDOS EXCITATÓRIOS, GLUTAMATOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GLASER, Talita et al. Various facets of excitotoxicity. Exploration of Neuroprotective Therapy, v. 2, p. 36–64, 2022Tradução . . Disponível em: https://doi.org/10.37349/ent.2022.00017. Acesso em: 12 nov. 2024.
APA
Glaser, T., Silva, J. B., Juvenal, G. A., Maiolini, P. N., Turrini, N., Petiz, L. L., et al. (2022). Various facets of excitotoxicity. Exploration of Neuroprotective Therapy, 2, 36–64. doi:10.37349/ent.2022.00017
NLM
Glaser T, Silva JB, Juvenal GA, Maiolini PN, Turrini N, Petiz LL, Marques LB, Ribeiro DE, Ye Q, Tang Y, Ulrich H. Various facets of excitotoxicity [Internet]. Exploration of Neuroprotective Therapy. 2022 ; 2 36–64.[citado 2024 nov. 12 ] Available from: https://doi.org/10.37349/ent.2022.00017
Vancouver
Glaser T, Silva JB, Juvenal GA, Maiolini PN, Turrini N, Petiz LL, Marques LB, Ribeiro DE, Ye Q, Tang Y, Ulrich H. Various facets of excitotoxicity [Internet]. Exploration of Neuroprotective Therapy. 2022 ; 2 36–64.[citado 2024 nov. 12 ] Available from: https://doi.org/10.37349/ent.2022.00017
Artigo de periodico
Distinct effects of the hippocampal transplantation of neural and mesenchymal stem cells in a transgenic model of Alzheimer's disease (2022)
Campos, Henrique C; Ribeiro, Deidiane Elisa ; Hashiguchi, Debora ; Hukuda, Deborah Y ; Gimenes, Christiane; Romariz, Simone A. A; Ye, Qing; Tang, Yong ; Ulrich, Henning ; Longo, Beatriz Monteiro
Fonte: Stem Cell Reviews and Reports. Unidade: IQ
Assuntos: CÉLULAS-TRONCO, DOENÇA DE ALZHEIMER, HIPOCAMPO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMPOS, Henrique C et al. Distinct effects of the hippocampal transplantation of neural and mesenchymal stem cells in a transgenic model of Alzheimer's disease. Stem Cell Reviews and Reports, v. 18, p. 781–791, 2022Tradução . . Disponível em: https://doi.org/10.1007/s12015-021-10321-9. Acesso em: 12 nov. 2024.
APA
Campos, H. C., Ribeiro, D. E., Hashiguchi, D., Hukuda, D. Y., Gimenes, C., Romariz, S. A. A., et al. (2022). Distinct effects of the hippocampal transplantation of neural and mesenchymal stem cells in a transgenic model of Alzheimer's disease. Stem Cell Reviews and Reports, 18, 781–791. doi:10.1007/s12015-021-10321-9
NLM
Campos HC, Ribeiro DE, Hashiguchi D, Hukuda DY, Gimenes C, Romariz SAA, Ye Q, Tang Y, Ulrich H, Longo BM. Distinct effects of the hippocampal transplantation of neural and mesenchymal stem cells in a transgenic model of Alzheimer's disease [Internet]. Stem Cell Reviews and Reports. 2022 ; 18 781–791.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1007/s12015-021-10321-9
Vancouver
Campos HC, Ribeiro DE, Hashiguchi D, Hukuda DY, Gimenes C, Romariz SAA, Ye Q, Tang Y, Ulrich H, Longo BM. Distinct effects of the hippocampal transplantation of neural and mesenchymal stem cells in a transgenic model of Alzheimer's disease [Internet]. Stem Cell Reviews and Reports. 2022 ; 18 781–791.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1007/s12015-021-10321-9
Artigo de periodico
A Neural circuit for gut-induced sugar preference (2021)
Cao, Xin; Yin, Hai-Yan; Ulrich, Henning ; Semyanov, Alexey ; Tang, Yong
Fonte: Neuroscience Bulletin. Unidade: IQ
Assuntos: AÇÚCAR, CÉREBRO, RECEPTORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAO, Xin et al. A Neural circuit for gut-induced sugar preference. Neuroscience Bulletin, v. 37, n. 5 p. 754–756, 2021Tradução . . Disponível em: https://doi.org/10.1007/s12264-021-00692-x. Acesso em: 12 nov. 2024.
APA
Cao, X., Yin, H. -Y., Ulrich, H., Semyanov, A., & Tang, Y. (2021). A Neural circuit for gut-induced sugar preference. Neuroscience Bulletin, 37( 5 p. 754–756). doi:10.1007/s12264-021-00692-x
NLM
Cao X, Yin H-Y, Ulrich H, Semyanov A, Tang Y. A Neural circuit for gut-induced sugar preference [Internet]. Neuroscience Bulletin. 2021 ; 37( 5 p. 754–756):[citado 2024 nov. 12 ] Available from: https://doi.org/10.1007/s12264-021-00692-x
Vancouver
Cao X, Yin H-Y, Ulrich H, Semyanov A, Tang Y. A Neural circuit for gut-induced sugar preference [Internet]. Neuroscience Bulletin. 2021 ; 37( 5 p. 754–756):[citado 2024 nov. 12 ] Available from: https://doi.org/10.1007/s12264-021-00692-x
Artigo de periodico
From purines to purinergic signalling: molecular functions and human diseases (2021)
Huang, Zhao; Xie, Na; Illes, Peter; Virgilio, Francesco Di ; Ulrich, Henning ; Semyanov, Alexey ; Verkhratsky, Alexei; Sperlagh, Beata; Yu, Shu-Guang; Huang, Canhua ; Tang, Yong
Fonte: Signal Transduction and Targeted Therapy. Unidade: IQ
Assuntos: PURINAS, DOENÇAS NEURODEGENERATIVAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HUANG, Zhao et al. From purines to purinergic signalling: molecular functions and human diseases. Signal Transduction and Targeted Therapy, v. 6, p. 1-20 art. 162, 2021Tradução . . Disponível em: https://doi.org/10.1038/s41392-021-00553-z. Acesso em: 12 nov. 2024.
APA
Huang, Z., Xie, N., Illes, P., Virgilio, F. D., Ulrich, H., Semyanov, A., et al. (2021). From purines to purinergic signalling: molecular functions and human diseases. Signal Transduction and Targeted Therapy, 6, 1-20 art. 162. doi:10.1038/s41392-021-00553-z
NLM
Huang Z, Xie N, Illes P, Virgilio FD, Ulrich H, Semyanov A, Verkhratsky A, Sperlagh B, Yu S-G, Huang C, Tang Y. From purines to purinergic signalling: molecular functions and human diseases [Internet]. Signal Transduction and Targeted Therapy. 2021 ; 6 1-20 art. 162.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1038/s41392-021-00553-z
Vancouver
Huang Z, Xie N, Illes P, Virgilio FD, Ulrich H, Semyanov A, Verkhratsky A, Sperlagh B, Yu S-G, Huang C, Tang Y. From purines to purinergic signalling: molecular functions and human diseases [Internet]. Signal Transduction and Targeted Therapy. 2021 ; 6 1-20 art. 162.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1038/s41392-021-00553-z
Artigo de periodico
Optical control of purinergic signaling (2021)
Wang, Tao; Ulrich, Henning ; Semyanov, Alexey ; Illes, Peter; Tang, Yong
Fonte: Purinergic Signalling. Unidade: IQ
Assuntos: RECEPTORES, ADENOSINA TRIFOSFATO, FARMACOLOGIA, BIOQUÍMICA, BIOLOGIA MOLECULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WANG, Tao et al. Optical control of purinergic signaling. Purinergic Signalling, v. 17, p. 385–392, 2021Tradução . . Disponível em: https://doi.org/10.1007/s11302-021-09799-2. Acesso em: 12 nov. 2024.
APA
Wang, T., Ulrich, H., Semyanov, A., Illes, P., & Tang, Y. (2021). Optical control of purinergic signaling. Purinergic Signalling, 17, 385–392. doi:10.1007/s11302-021-09799-2
NLM
Wang T, Ulrich H, Semyanov A, Illes P, Tang Y. Optical control of purinergic signaling [Internet]. Purinergic Signalling. 2021 ; 17 385–392.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1007/s11302-021-09799-2
Vancouver
Wang T, Ulrich H, Semyanov A, Illes P, Tang Y. Optical control of purinergic signaling [Internet]. Purinergic Signalling. 2021 ; 17 385–392.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1007/s11302-021-09799-2
Artigo de periodico
Regulation of microglial functions by purinergic mechanisms in the healthy and diseased CNS (2020)
Illes, Peter Illes Peter; Rubini, Patrizia; Ulrich, Henning ; Zhao, Yafei; Tang, Yong
Fonte: Cells. Unidade: IQ
Assuntos: FAGOCITOSE, MACRÓFAGOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ILLES, Peter Illes Peter et al. Regulation of microglial functions by purinergic mechanisms in the healthy and diseased CNS. Cells, v. 9, n. 5, p. 1-24 art. 1108, 2020Tradução . . Disponível em: https://doi.org/10.3390/cells9051108. Acesso em: 12 nov. 2024.
APA
Illes, P. I. P., Rubini, P., Ulrich, H., Zhao, Y., & Tang, Y. (2020). Regulation of microglial functions by purinergic mechanisms in the healthy and diseased CNS. Cells, 9( 5), 1-24 art. 1108. doi:10.3390/cells9051108
NLM
Illes PIP, Rubini P, Ulrich H, Zhao Y, Tang Y. Regulation of microglial functions by purinergic mechanisms in the healthy and diseased CNS [Internet]. Cells. 2020 ; 9( 5): 1-24 art. 1108.[citado 2024 nov. 12 ] Available from: https://doi.org/10.3390/cells9051108
Vancouver
Illes PIP, Rubini P, Ulrich H, Zhao Y, Tang Y. Regulation of microglial functions by purinergic mechanisms in the healthy and diseased CNS [Internet]. Cells. 2020 ; 9( 5): 1-24 art. 1108.[citado 2024 nov. 12 ] Available from: https://doi.org/10.3390/cells9051108
Artigo de periodico
TASK-3: new target for pain-relief (2020)
Ren, Wen-Jing; Ulrich, Henning ; Semyanov, Alexey; Illes, Peter; Tang, Yong
Fonte: Neuroscience Bulletin. Unidade: IQ
Assuntos: ANALGÉSICOS, DOR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
REN, Wen-Jing et al. TASK-3: new target for pain-relief. Neuroscience Bulletin, v. 36, n. 8, p. 951–954, 2020Tradução . . Disponível em: https://doi.org/10.1007/s12264-020-00516-4. Acesso em: 12 nov. 2024.
APA
Ren, W. -J., Ulrich, H., Semyanov, A., Illes, P., & Tang, Y. (2020). TASK-3: new target for pain-relief. Neuroscience Bulletin, 36( 8), 951–954. doi:10.1007/s12264-020-00516-4
NLM
Ren W-J, Ulrich H, Semyanov A, Illes P, Tang Y. TASK-3: new target for pain-relief [Internet]. Neuroscience Bulletin. 2020 ; 36( 8): 951–954.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1007/s12264-020-00516-4
Vancouver
Ren W-J, Ulrich H, Semyanov A, Illes P, Tang Y. TASK-3: new target for pain-relief [Internet]. Neuroscience Bulletin. 2020 ; 36( 8): 951–954.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1007/s12264-020-00516-4
Artigo de periodico
Purinergic receptors in basal ganglia diseases: shared molecular Mechanisms between huntington’s and parkinson’s disease (2020)
Glaser, Talita ; Andrejew, Roberta ; Giacomelli, Ágatha Oliveira ; Ribeiro, Deidiane Elisa ; Marques, Lucas Bonfim; Ye, Qing; Ren, Wen-Jing; Semyanov, Alexey; Illes, Peter; Tang, Yong; Ulrich, Henning
Fonte: Neuroscience Bulletin. Unidade: IQ
Assuntos: RECEPTORES, DOENÇA DE PARKINSON, DOENÇAS DOS GÂNGLIOS DE BASE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GLASER, Talita et al. Purinergic receptors in basal ganglia diseases: shared molecular Mechanisms between huntington’s and parkinson’s disease. Neuroscience Bulletin, v. 36, n. 11, p. 1299–1314, 2020Tradução . . Disponível em: https://doi.org/10.1007/s12264-020-00582-8. Acesso em: 12 nov. 2024.
APA
Glaser, T., Andrejew, R., Giacomelli, Á. O., Ribeiro, D. E., Marques, L. B., Ye, Q., et al. (2020). Purinergic receptors in basal ganglia diseases: shared molecular Mechanisms between huntington’s and parkinson’s disease. Neuroscience Bulletin, 36( 11), 1299–1314. doi:10.1007/s12264-020-00582-8
NLM
Glaser T, Andrejew R, Giacomelli ÁO, Ribeiro DE, Marques LB, Ye Q, Ren W-J, Semyanov A, Illes P, Tang Y, Ulrich H. Purinergic receptors in basal ganglia diseases: shared molecular Mechanisms between huntington’s and parkinson’s disease [Internet]. Neuroscience Bulletin. 2020 ; 36( 11): 1299–1314.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1007/s12264-020-00582-8
Vancouver
Glaser T, Andrejew R, Giacomelli ÁO, Ribeiro DE, Marques LB, Ye Q, Ren W-J, Semyanov A, Illes P, Tang Y, Ulrich H. Purinergic receptors in basal ganglia diseases: shared molecular Mechanisms between huntington’s and parkinson’s disease [Internet]. Neuroscience Bulletin. 2020 ; 36( 11): 1299–1314.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1007/s12264-020-00582-8

Unidades USP

ReP

Filtros

Autores

Autores USP

Assuntos

Título da fonte

Agência de fomento

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos